Global and China Needle-Free Drug Delivery Systems Market Insights, Forecast to 2026

Publisher Name :
Date: 25-Sep-2020
No. of pages: 143
Inquire Before Buying

Needle-Free Drug Delivery Systems market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Needle-Free Drug Delivery Systems market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2015-2026.

Segment by Type, the Needle-Free Drug Delivery Systems market is segmented into

- Jet-based

- Spring-based

- Laser-based

Segment by Application, the Needle-Free Drug Delivery Systems market is segmented into

- Hospital

- Clinic

- Other

Regional and Country-level Analysis

The Needle-Free Drug Delivery Systems market is analysed and market size information is provided by regions (countries).

The key regions covered in the Needle-Free Drug Delivery Systems market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.

The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.

Competitive Landscape and Needle-Free Drug Delivery Systems Market Share Analysis

Needle-Free Drug Delivery Systems market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Needle-Free Drug Delivery Systems business, the date to enter into the Needle-Free Drug Delivery Systems market, Needle-Free Drug Delivery Systems product introduction, recent developments, etc.

The major vendors covered:

- Antares Pharma

- Pharmajet

- Optinose

- Valeritas

- Crossject

- Injex Pharma

- 3M Pharmaceuticals

- Becton Dickinson (BD)

- MedImmune

- Mystic Pharmaceuticals

- Zogenix

Global and China Needle-Free Drug Delivery Systems Market Insights, Forecast to 2026

Table of Contents
1 Study Coverage
1.1 Needle-Free Drug Delivery Systems Product Introduction
1.2 Market Segments
1.3 Key Needle-Free Drug Delivery Systems Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Needle-Free Drug Delivery Systems Market Size Growth Rate by Type
1.4.2 Jet-based
1.4.3 Spring-based
1.4.4 Laser-based
1.5 Market by Application
1.5.1 Global Needle-Free Drug Delivery Systems Market Size Growth Rate by Application
1.5.2 Hospital
1.5.3 Clinic
1.5.4 Other
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Needle-Free Drug Delivery Systems Market Size, Estimates and Forecasts
2.1.1 Global Needle-Free Drug Delivery Systems Revenue 2015-2026
2.1.2 Global Needle-Free Drug Delivery Systems Sales 2015-2026
2.2 Global Needle-Free Drug Delivery Systems, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.3 Needle-Free Drug Delivery Systems Historical Market Size by Region (2015-2020)
2.3.1 Global Needle-Free Drug Delivery Systems Retrospective Market Scenario in Sales by Region: 2015-2020
2.3.2 Global Needle-Free Drug Delivery Systems Retrospective Market Scenario in Revenue by Region: 2015-2020
2.4 Needle-Free Drug Delivery Systems Market Estimates and Projections by Region (2021-2026)
2.4.1 Global Needle-Free Drug Delivery Systems Sales Forecast by Region (2021-2026)
2.4.2 Global Needle-Free Drug Delivery Systems Revenue Forecast by Region (2021-2026)
3 Global Needle-Free Drug Delivery Systems Competitor Landscape by Players
3.1 Global Top Needle-Free Drug Delivery Systems Sales by Manufacturers
3.1.1 Global Needle-Free Drug Delivery Systems Sales by Manufacturers (2015-2020)
3.1.2 Global Needle-Free Drug Delivery Systems Sales Market Share by Manufacturers (2015-2020)
3.2 Global Needle-Free Drug Delivery Systems Manufacturers by Revenue
3.2.1 Global Needle-Free Drug Delivery Systems Revenue by Manufacturers (2015-2020)
3.2.2 Global Needle-Free Drug Delivery Systems Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Needle-Free Drug Delivery Systems Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Needle-Free Drug Delivery Systems Revenue in 2019
3.2.5 Global Needle-Free Drug Delivery Systems Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Needle-Free Drug Delivery Systems Price by Manufacturers
3.4 Global Needle-Free Drug Delivery Systems Manufacturing Base Distribution, Product Types
3.4.1 Needle-Free Drug Delivery Systems Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Needle-Free Drug Delivery Systems Product Type
3.4.3 Date of International Manufacturers Enter into Needle-Free Drug Delivery Systems Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Needle-Free Drug Delivery Systems Market Size by Type (2015-2020)
4.1.1 Global Needle-Free Drug Delivery Systems Sales by Type (2015-2020)
4.1.2 Global Needle-Free Drug Delivery Systems Revenue by Type (2015-2020)
4.1.3 Needle-Free Drug Delivery Systems Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Needle-Free Drug Delivery Systems Market Size Forecast by Type (2021-2026)
4.2.1 Global Needle-Free Drug Delivery Systems Sales Forecast by Type (2021-2026)
4.2.2 Global Needle-Free Drug Delivery Systems Revenue Forecast by Type (2021-2026)
4.2.3 Needle-Free Drug Delivery Systems Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Needle-Free Drug Delivery Systems Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Needle-Free Drug Delivery Systems Market Size by Application (2015-2020)
5.1.1 Global Needle-Free Drug Delivery Systems Sales by Application (2015-2020)
5.1.2 Global Needle-Free Drug Delivery Systems Revenue by Application (2015-2020)
5.1.3 Needle-Free Drug Delivery Systems Price by Application (2015-2020)
5.2 Needle-Free Drug Delivery Systems Market Size Forecast by Application (2021-2026)
5.2.1 Global Needle-Free Drug Delivery Systems Sales Forecast by Application (2021-2026)
5.2.2 Global Needle-Free Drug Delivery Systems Revenue Forecast by Application (2021-2026)
5.2.3 Global Needle-Free Drug Delivery Systems Price Forecast by Application (2021-2026)
6 China by Players, Type and Application
6.1 China Needle-Free Drug Delivery Systems Market Size YoY Growth 2015-2026
6.1.1 China Needle-Free Drug Delivery Systems Sales YoY Growth 2015-2026
6.1.2 China Needle-Free Drug Delivery Systems Revenue YoY Growth 2015-2026
6.1.3 China Needle-Free Drug Delivery Systems Market Share in Global Market 2015-2026
6.2 China Needle-Free Drug Delivery Systems Market Size by Players (International and Local Players)
6.2.1 China Top Needle-Free Drug Delivery Systems Players by Sales (2015-2020)
6.2.2 China Top Needle-Free Drug Delivery Systems Players by Revenue (2015-2020)
6.3 China Needle-Free Drug Delivery Systems Historic Market Review by Type (2015-2020)
6.3.1 China Needle-Free Drug Delivery Systems Sales Market Share by Type (2015-2020)
6.3.2 China Needle-Free Drug Delivery Systems Revenue Market Share by Type (2015-2020)
6.3.3 China Needle-Free Drug Delivery Systems Price by Type (2015-2020)
6.4 China Needle-Free Drug Delivery Systems Market Estimates and Forecasts by Type (2021-2026)
6.4.1 China Needle-Free Drug Delivery Systems Sales Forecast by Type (2021-2026)
6.4.2 China Needle-Free Drug Delivery Systems Revenue Forecast by Type (2021-2026)
6.4.3 China Needle-Free Drug Delivery Systems Price Forecast by Type (2021-2026)
6.5 China Needle-Free Drug Delivery Systems Historic Market Review by Application (2015-2020)
6.5.1 China Needle-Free Drug Delivery Systems Sales Market Share by Application (2015-2020)
6.5.2 China Needle-Free Drug Delivery Systems Revenue Market Share by Application (2015-2020)
6.5.3 China Needle-Free Drug Delivery Systems Price by Application (2015-2020)
6.6 China Needle-Free Drug Delivery Systems Market Estimates and Forecasts by Application (2021-2026)
6.6.1 China Needle-Free Drug Delivery Systems Sales Forecast by Application (2021-2026)
6.6.2 China Needle-Free Drug Delivery Systems Revenue Forecast by Application (2021-2026)
6.6.3 China Needle-Free Drug Delivery Systems Price Forecast by Application (2021-2026)
7 North America
7.1 North America Needle-Free Drug Delivery Systems Market Size YoY Growth 2015-2026
7.2 North America Needle-Free Drug Delivery Systems Market Facts & Figures by Country
7.2.1 North America Needle-Free Drug Delivery Systems Sales by Country (2015-2020)
7.2.2 North America Needle-Free Drug Delivery Systems Revenue by Country (2015-2020)
7.2.3 U.S.
7.2.4 Canada
8 Europe
8.1 Europe Needle-Free Drug Delivery Systems Market Size YoY Growth 2015-2026
8.2 Europe Needle-Free Drug Delivery Systems Market Facts & Figures by Country
8.2.1 Europe Needle-Free Drug Delivery Systems Sales by Country
8.2.2 Europe Needle-Free Drug Delivery Systems Revenue by Country
8.2.3 Germany
8.2.4 France
8.2.5 U.K.
8.2.6 Italy
8.2.7 Russia
9 Asia Pacific
9.1 Asia Pacific Needle-Free Drug Delivery Systems Market Size YoY Growth 2015-2026
9.2 Asia Pacific Needle-Free Drug Delivery Systems Market Facts & Figures by Country
9.2.1 Asia Pacific Needle-Free Drug Delivery Systems Sales by Region (2015-2020)
9.2.2 Asia Pacific Needle-Free Drug Delivery Systems Revenue by Region
9.2.3 China
9.2.4 Japan
9.2.5 South Korea
9.2.6 India
9.2.7 Australia
9.2.8 Taiwan
9.2.9 Indonesia
9.2.10 Thailand
9.2.11 Malaysia
9.2.12 Philippines
9.2.13 Vietnam
10 Latin America
10.1 Latin America Needle-Free Drug Delivery Systems Market Size YoY Growth 2015-2026
10.2 Latin America Needle-Free Drug Delivery Systems Market Facts & Figures by Country
10.2.1 Latin America Needle-Free Drug Delivery Systems Sales by Country
10.2.2 Latin America Needle-Free Drug Delivery Systems Revenue by Country
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Needle-Free Drug Delivery Systems Market Size YoY Growth 2015-2026
11.2 Middle East and Africa Needle-Free Drug Delivery Systems Market Facts & Figures by Country
11.2.1 Middle East and Africa Needle-Free Drug Delivery Systems Sales by Country
11.2.2 Middle East and Africa Needle-Free Drug Delivery Systems Revenue by Country
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 U.A.E
12 Company Profiles
12.1 Antares Pharma
12.1.1 Antares Pharma Corporation Information
12.1.2 Antares Pharma Description and Business Overview
12.1.3 Antares Pharma Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Antares Pharma Needle-Free Drug Delivery Systems Products Offered
12.1.5 Antares Pharma Recent Development
12.2 Pharmajet
12.2.1 Pharmajet Corporation Information
12.2.2 Pharmajet Description and Business Overview
12.2.3 Pharmajet Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Pharmajet Needle-Free Drug Delivery Systems Products Offered
12.2.5 Pharmajet Recent Development
12.3 Optinose
12.3.1 Optinose Corporation Information
12.3.2 Optinose Description and Business Overview
12.3.3 Optinose Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Optinose Needle-Free Drug Delivery Systems Products Offered
12.3.5 Optinose Recent Development
12.4 Valeritas
12.4.1 Valeritas Corporation Information
12.4.2 Valeritas Description and Business Overview
12.4.3 Valeritas Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Valeritas Needle-Free Drug Delivery Systems Products Offered
12.4.5 Valeritas Recent Development
12.5 Crossject
12.5.1 Crossject Corporation Information
12.5.2 Crossject Description and Business Overview
12.5.3 Crossject Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Crossject Needle-Free Drug Delivery Systems Products Offered
12.5.5 Crossject Recent Development
12.6 Injex Pharma
12.6.1 Injex Pharma Corporation Information
12.6.2 Injex Pharma Description and Business Overview
12.6.3 Injex Pharma Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Injex Pharma Needle-Free Drug Delivery Systems Products Offered
12.6.5 Injex Pharma Recent Development
12.7 3M Pharmaceuticals
12.7.1 3M Pharmaceuticals Corporation Information
12.7.2 3M Pharmaceuticals Description and Business Overview
12.7.3 3M Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
12.7.4 3M Pharmaceuticals Needle-Free Drug Delivery Systems Products Offered
12.7.5 3M Pharmaceuticals Recent Development
12.8 Becton Dickinson (BD)
12.8.1 Becton Dickinson (BD) Corporation Information
12.8.2 Becton Dickinson (BD) Description and Business Overview
12.8.3 Becton Dickinson (BD) Sales, Revenue and Gross Margin (2015-2020)
12.8.4 Becton Dickinson (BD) Needle-Free Drug Delivery Systems Products Offered
12.8.5 Becton Dickinson (BD) Recent Development
12.9 MedImmune
12.9.1 MedImmune Corporation Information
12.9.2 MedImmune Description and Business Overview
12.9.3 MedImmune Sales, Revenue and Gross Margin (2015-2020)
12.9.4 MedImmune Needle-Free Drug Delivery Systems Products Offered
12.9.5 MedImmune Recent Development
12.10 Mystic Pharmaceuticals
12.10.1 Mystic Pharmaceuticals Corporation Information
12.10.2 Mystic Pharmaceuticals Description and Business Overview
12.10.3 Mystic Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
12.10.4 Mystic Pharmaceuticals Needle-Free Drug Delivery Systems Products Offered
12.10.5 Mystic Pharmaceuticals Recent Development
12.11 Antares Pharma
12.11.1 Antares Pharma Corporation Information
12.11.2 Antares Pharma Description and Business Overview
12.11.3 Antares Pharma Sales, Revenue and Gross Margin (2015-2020)
12.11.4 Antares Pharma Needle-Free Drug Delivery Systems Products Offered
12.11.5 Antares Pharma Recent Development
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter's Five Forces Analysis
13.5 Primary Interviews with Key Needle-Free Drug Delivery Systems Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Needle-Free Drug Delivery Systems Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables
Table 1. Needle-Free Drug Delivery Systems Market Segments
Table 2. Ranking of Global Top Needle-Free Drug Delivery Systems Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Needle-Free Drug Delivery Systems Market Size Growth Rate by Type 2020-2026 (K Units) & (US$ Million)
Table 4. Major Manufacturers of Jet-based
Table 5. Major Manufacturers of Spring-based
Table 6. Major Manufacturers of Laser-based
Table 7. Global Needle-Free Drug Delivery Systems Market Size Growth Rate by Application 2020-2026 (K Units)
Table 8. Global Needle-Free Drug Delivery Systems Market Size by Region (K Units) & (US$ Million): 2020 VS 2026
Table 9. Global Needle-Free Drug Delivery Systems Sales by Regions 2015-2020 (K Units)
Table 10. Global Needle-Free Drug Delivery Systems Sales Market Share by Regions (2015-2020)
Table 11. Global Needle-Free Drug Delivery Systems Revenue by Regions 2015-2020 (US$ Million)
Table 12. Global Needle-Free Drug Delivery Systems Sales Forecast by Region (2021-2026) (K Units)
Table 13. Global Needle-Free Drug Delivery Systems Sales by Manufacturers (2015-2020) (K Units)
Table 14. Global Needle-Free Drug Delivery Systems Sales Share by Manufacturers (2015-2020)
Table 15. Global Needle-Free Drug Delivery Systems Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 16. Global Needle-Free Drug Delivery Systems by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Needle-Free Drug Delivery Systems as of 2019)
Table 17. Needle-Free Drug Delivery Systems Revenue by Manufacturers (2015-2020) (US$ Million)
Table 18. Needle-Free Drug Delivery Systems Revenue Share by Manufacturers (2015-2020)
Table 19. Key Manufacturers Needle-Free Drug Delivery Systems Price (2015-2020) (USD/Unit)
Table 20. Needle-Free Drug Delivery Systems Manufacturers Manufacturing Base Distribution and Headquarters
Table 21. Manufacturers Needle-Free Drug Delivery Systems Product Type
Table 22. Date of International Manufacturers Enter into Needle-Free Drug Delivery Systems Market
Table 23. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 24. Global Needle-Free Drug Delivery Systems Sales by Type (2015-2020) (K Units)
Table 25. Global Needle-Free Drug Delivery Systems Sales Share by Type (2015-2020)
Table 26. Global Needle-Free Drug Delivery Systems Revenue by Type (2015-2020) (US$ Million)
Table 27. Global Needle-Free Drug Delivery Systems Revenue Share by Type (2015-2020)
Table 28. Needle-Free Drug Delivery Systems Average Selling Price (ASP) by Type 2015-2020 (USD/Unit)
Table 29. Global Needle-Free Drug Delivery Systems Sales Share by Type (2021-2026)
Table 30. Global Needle-Free Drug Delivery Systems Sales by Application (2015-2020) (K Units)
Table 31. Global Needle-Free Drug Delivery Systems Sales Share by Application (2015-2020)
Table 32. Global Needle-Free Drug Delivery Systems Sales Share by Application (2021-2026)
Table 33. Global Needle-Free Drug Delivery Systems Sales Market Share Forecast by Application (2021-2026)
Table 34. Global Needle-Free Drug Delivery Systems Revenue by Application (2015-2020) (US$ Million)
Table 35. Global Needle-Free Drug Delivery Systems Revenue Market Share Forecast by Application (2021-2026)
Table 36. China Needle-Free Drug Delivery Systems Sales (K Units) of Key Companies (2015-2020)
Table 37. China Needle-Free Drug Delivery Systems Sales Share by Company (2015-2020)
Table 38. China Needle-Free Drug Delivery Systems Revenue (US$ Million) by Company (2015-2020)
Table 39. China Needle-Free Drug Delivery Systems Sales (K Units) by Type (2015-2020)
Table 40. China Needle-Free Drug Delivery Systems Sales Share by Type (2015-2020)
Table 41. China Needle-Free Drug Delivery Systems Revenue (US$ Million) Market Share by Type (2015-2020)
Table 42. China Needle-Free Drug Delivery Systems Price (K Units) by Type (2015-2020)
Table 43. China Needle-Free Drug Delivery Systems Sales (K Units) by Type (2021-2026)
Table 44. China Needle-Free Drug Delivery Systems Sales Share by Type (2021-2026)
Table 45. China Needle-Free Drug Delivery Systems Revenue (US$ Million) Market Share by Type (2021-2026)
Table 46. China Needle-Free Drug Delivery Systems Revenue Share by Type (2021-2026)
Table 47. China Needle-Free Drug Delivery Systems Price (K Units) by Type (2021-2026)
Table 48. China Needle-Free Drug Delivery Systems Sales (K Units) by Application (2015-2020)
Table 49. China Needle-Free Drug Delivery Systems Sales Share by Application (2015-2020)
Table 50. China Needle-Free Drug Delivery Systems Revenue (US$ Million) Market Share by Application (2015-2020)
Table 51. China Needle-Free Drug Delivery Systems Sales (K Units) by Application (2021-2026)
Table 52. China Needle-Free Drug Delivery Systems Sales Share by Application (2021-2026)
Table 53. China Needle-Free Drug Delivery Systems Revenue (US$ Million) Market Share by Application (2021-2026)
Table 54. China Needle-Free Drug Delivery Systems Revenue Share by Application (2021-2026)
Table 55. North America Needle-Free Drug Delivery Systems Sales by Country (2015-2020) (K Units)
Table 56. North America Needle-Free Drug Delivery Systems Sales Market Share by Country (2015-2020)
Table 57. North America Needle-Free Drug Delivery Systems Revenue by Country (2015-2020) (US$ Million)
Table 58. North America Needle-Free Drug Delivery Systems Revenue Market Share by Country (2015-2020)
Table 59. Europe Needle-Free Drug Delivery Systems Sales by Country (2015-2020) (K Units)
Table 60. Europe Needle-Free Drug Delivery Systems Sales Market Share by Country (2015-2020)
Table 61. Europe Needle-Free Drug Delivery Systems Revenue by Country (2015-2020) (US$ Million)
Table 62. Europe Needle-Free Drug Delivery Systems Revenue Market Share by Country (2015-2020)
Table 63. Asia Pacific Needle-Free Drug Delivery Systems Sales by Region (2015-2020) (K Units)
Table 64. Asia Pacific Needle-Free Drug Delivery Systems Sales Market Share by Region (2015-2020)
Table 65. Asia Pacific Needle-Free Drug Delivery Systems Revenue by Region (2015-2020) (US$ Million)
Table 66. Asia Pacific Needle-Free Drug Delivery Systems Revenue Market Share by Region (2015-2020)
Table 67. Latin America Needle-Free Drug Delivery Systems Sales by Country (2015-2020) (K Units)
Table 68. Latin America Needle-Free Drug Delivery Systems Sales Market Share by Country (2015-2020)
Table 69. Latin Americaa Needle-Free Drug Delivery Systems Revenue by Country (2015-2020) (US$ Million)
Table 70. Latin America Needle-Free Drug Delivery Systems Revenue Market Share by Country (2015-2020)
Table 71. Middle East and Africa Needle-Free Drug Delivery Systems Sales by Country (2015-2020) (K Units)
Table 72. Middle East and Africa Needle-Free Drug Delivery Systems Sales Market Share by Country (2015-2020)
Table 73. Middle East and Africa Needle-Free Drug Delivery Systems Revenue by Country (2015-2020) (US$ Million)
Table 74. Middle East and Africa Needle-Free Drug Delivery Systems Revenue Market Share by Country (2015-2020)
Table 75. Antares Pharma Corporation Information
Table 76. Antares Pharma Description and Business Overview
Table 77. Antares Pharma Needle-Free Drug Delivery Systems Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 78. Antares Pharma Needle-Free Drug Delivery Systems Product
Table 79. Antares Pharma Recent Development
Table 80. Pharmajet Corporation Information
Table 81. Pharmajet Description and Business Overview
Table 82. Pharmajet Needle-Free Drug Delivery Systems Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 83. Pharmajet Product
Table 84. Pharmajet Recent Development
Table 85. Optinose Corporation Information
Table 86. Optinose Description and Business Overview
Table 87. Optinose Needle-Free Drug Delivery Systems Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 88. Optinose Product
Table 89. Optinose Recent Development
Table 90. Valeritas Corporation Information
Table 91. Valeritas Description and Business Overview
Table 92. Valeritas Needle-Free Drug Delivery Systems Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 93. Valeritas Product
Table 94. Valeritas Recent Development
Table 95. Crossject Corporation Information
Table 96. Crossject Description and Business Overview
Table 97. Crossject Needle-Free Drug Delivery Systems Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 98. Crossject Product
Table 99. Crossject Recent Development
Table 100. Injex Pharma Corporation Information
Table 101. Injex Pharma Description and Business Overview
Table 102. Injex Pharma Needle-Free Drug Delivery Systems Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 103. Injex Pharma Product
Table 104. Injex Pharma Recent Development
Table 105. 3M Pharmaceuticals Corporation Information
Table 106. 3M Pharmaceuticals Description and Business Overview
Table 107. 3M Pharmaceuticals Needle-Free Drug Delivery Systems Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 108. 3M Pharmaceuticals Product
Table 109. 3M Pharmaceuticals Recent Development
Table 110. Becton Dickinson (BD) Corporation Information
Table 111. Becton Dickinson (BD) Description and Business Overview
Table 112. Becton Dickinson (BD) Needle-Free Drug Delivery Systems Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 113. Becton Dickinson (BD) Product
Table 114. Becton Dickinson (BD) Recent Development
Table 115. MedImmune Corporation Information
Table 116. MedImmune Description and Business Overview
Table 117. MedImmune Needle-Free Drug Delivery Systems Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 118. MedImmune Product
Table 119. MedImmune Recent Development
Table 120. Mystic Pharmaceuticals Corporation Information
Table 121. Mystic Pharmaceuticals Description and Business Overview
Table 122. Mystic Pharmaceuticals Needle-Free Drug Delivery Systems Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 123. Mystic Pharmaceuticals Product
Table 124. Mystic Pharmaceuticals Recent Development
Table 125. Zogenix Corporation Information
Table 126. Zogenix Description and Business Overview
Table 127. Zogenix Needle-Free Drug Delivery Systems Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 128. Zogenix Product
Table 129. Zogenix Recent Development
Table 130. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 131. Key Challenges
Table 132. Market Risks
Table 133. Main Points Interviewed from Key Needle-Free Drug Delivery Systems Players
Table 134. Needle-Free Drug Delivery Systems Customers List
Table 135. Needle-Free Drug Delivery Systems Distributors List
Table 136. Research Programs/Design for This Report
Table 137. Key Data Information from Secondary Sources
Table 138. Key Data Information from Primary Sources
List of Figures
Figure 1. Needle-Free Drug Delivery Systems Product Picture
Figure 2. Global Needle-Free Drug Delivery Systems Sales Market Share by Type in 2020 & 2026
Figure 3. Jet-based Product Picture
Figure 4. Spring-based Product Picture
Figure 5. Laser-based Product Picture
Figure 6. Global Needle-Free Drug Delivery Systems Sales Market Share by Application in 2020 & 2026
Figure 7. Hospital
Figure 8. Clinic
Figure 9. Other
Figure 10. Needle-Free Drug Delivery Systems Report Years Considered
Figure 11. Global Needle-Free Drug Delivery Systems Market Size 2015-2026 (US$ Million)
Figure 12. Global Needle-Free Drug Delivery Systems Sales 2015-2026 (K Units)
Figure 13. Global Needle-Free Drug Delivery Systems Market Size Market Share by Region: 2020 Versus 2026
Figure 14. Global Needle-Free Drug Delivery Systems Sales Market Share by Region (2015-2020)
Figure 15. Global Needle-Free Drug Delivery Systems Sales Market Share by Region in 2019
Figure 16. Global Needle-Free Drug Delivery Systems Revenue Market Share by Region (2015-2020)
Figure 17. Global Needle-Free Drug Delivery Systems Revenue Market Share by Region in 2019
Figure 18. Global Needle-Free Drug Delivery Systems Sales Share by Manufacturer in 2019
Figure 19. The Top 10 and 5 Players Market Share by Needle-Free Drug Delivery Systems Revenue in 2019
Figure 20. Needle-Free Drug Delivery Systems Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 21. Global Needle-Free Drug Delivery Systems Sales Market Share by Type (2015-2020)
Figure 22. Global Needle-Free Drug Delivery Systems Sales Market Share by Type in 2019
Figure 23. Global Needle-Free Drug Delivery Systems Revenue Market Share by Type (2015-2020)
Figure 24. Global Needle-Free Drug Delivery Systems Revenue Market Share by Type in 2019
Figure 25. Global Needle-Free Drug Delivery Systems Market Share by Price Range (2015-2020)
Figure 26. Global Needle-Free Drug Delivery Systems Sales Market Share by Application (2015-2020)
Figure 27. Global Needle-Free Drug Delivery Systems Sales Market Share by Application in 2019
Figure 28. Global Needle-Free Drug Delivery Systems Revenue Market Share by Application (2015-2020)
Figure 29. Global Needle-Free Drug Delivery Systems Revenue Market Share by Application in 2019
Figure 30. China Needle-Free Drug Delivery Systems Sales Growth Rate 2015-2026 (K Units)
Figure 31. China Needle-Free Drug Delivery Systems Revenue Growth Rate 2015-2026 (US$ Million)
Figure 32. China Needle-Free Drug Delivery Systems Market Share in Global Market 2015-2026
Figure 33. China 5 and 10 Largest Needle-Free Drug Delivery Systems Players Market Share by Revenue in Needle-Free Drug Delivery Systems in 2019
Figure 34. China Needle-Free Drug Delivery Systems Revenue Share by Type (2015-2020)
Figure 35. China Needle-Free Drug Delivery Systems Revenue Growth Rate by Type in 2015 & 2019
Figure 36. China Needle-Free Drug Delivery Systems Revenue Share by Application (2015-2020)
Figure 37. China Needle-Free Drug Delivery Systems Revenue Growth Rate by Application in 2015 & 2019
Figure 38. North America Needle-Free Drug Delivery Systems Sales Growth Rate 2015-2020 (K Units)
Figure 39. North America Needle-Free Drug Delivery Systems Revenue Growth Rate 2015-2020 (US$ Million)
Figure 40. North America Needle-Free Drug Delivery Systems Sales Market Share by Country in 2019
Figure 41. North America Needle-Free Drug Delivery Systems Revenue Market Share by Country in 2019
Figure 42. U.S. Needle-Free Drug Delivery Systems Sales Growth Rate (2015-2020) (K Units)
Figure 43. U.S. Needle-Free Drug Delivery Systems Revenue Growth Rate (2015-2020) (US$ Million)
Figure 44. Canada Needle-Free Drug Delivery Systems Sales Growth Rate (2015-2020) (K Units)
Figure 45. Canada Needle-Free Drug Delivery Systems Revenue Growth Rate (2015-2020) (US$ Million)
Figure 46. Europe Needle-Free Drug Delivery Systems Sales Growth Rate 2015-2020 (K Units)
Figure 47. Europe Needle-Free Drug Delivery Systems Revenue Growth Rate 2015-2020 (US$ Million)
Figure 48. Europe Needle-Free Drug Delivery Systems Sales Market Share by Country in 2019
Figure 49. Europe Needle-Free Drug Delivery Systems Revenue Market Share by Country in 2019
Figure 50. Germany Needle-Free Drug Delivery Systems Sales Growth Rate (2015-2020) (K Units)
Figure 51. Germany Needle-Free Drug Delivery Systems Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. France Needle-Free Drug Delivery Systems Sales Growth Rate (2015-2020) (K Units)
Figure 53. France Needle-Free Drug Delivery Systems Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. U.K. Needle-Free Drug Delivery Systems Sales Growth Rate (2015-2020) (K Units)
Figure 55. U.K. Needle-Free Drug Delivery Systems Revenue Growth Rate (2015-2020) (US$ Million)
Figure 56. Italy Needle-Free Drug Delivery Systems Sales Growth Rate (2015-2020) (K Units)
Figure 57. Italy Needle-Free Drug Delivery Systems Revenue Growth Rate (2015-2020) (US$ Million)
Figure 58. Russia Needle-Free Drug Delivery Systems Sales Growth Rate (2015-2020) (K Units)
Figure 59. Russia Needle-Free Drug Delivery Systems Revenue Growth Rate (2015-2020) (US$ Million)
Figure 60. Asia Pacific Needle-Free Drug Delivery Systems Sales Growth Rate 2015-2020 (K Units)
Figure 61. Asia Pacific Needle-Free Drug Delivery Systems Revenue Growth Rate 2015-2020 (US$ Million)
Figure 62. Asia Pacific Needle-Free Drug Delivery Systems Sales Market Share by Region in 2019
Figure 63. Asia Pacific Needle-Free Drug Delivery Systems Revenue Market Share by Region in 2019
Figure 64. China Needle-Free Drug Delivery Systems Sales Growth Rate (2015-2020) (K Units)
Figure 65. China Needle-Free Drug Delivery Systems Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. Japan Needle-Free Drug Delivery Systems Sales Growth Rate (2015-2020) (K Units)
Figure 67. Japan Needle-Free Drug Delivery Systems Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. South Korea Needle-Free Drug Delivery Systems Sales Growth Rate (2015-2020) (K Units)
Figure 69. South Korea Needle-Free Drug Delivery Systems Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. India Needle-Free Drug Delivery Systems Sales Growth Rate (2015-2020) (K Units)
Figure 71. India Needle-Free Drug Delivery Systems Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Australia Needle-Free Drug Delivery Systems Sales Growth Rate (2015-2020) (K Units)
Figure 73. Australia Needle-Free Drug Delivery Systems Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Taiwan Needle-Free Drug Delivery Systems Sales Growth Rate (2015-2020) (K Units)
Figure 75. Taiwan Needle-Free Drug Delivery Systems Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Indonesia Needle-Free Drug Delivery Systems Sales Growth Rate (2015-2020) (K Units)
Figure 77. Indonesia Needle-Free Drug Delivery Systems Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Thailand Needle-Free Drug Delivery Systems Sales Growth Rate (2015-2020) (K Units)
Figure 79. Thailand Needle-Free Drug Delivery Systems Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Malaysia Needle-Free Drug Delivery Systems Sales Growth Rate (2015-2020) (K Units)
Figure 81. Malaysia Needle-Free Drug Delivery Systems Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. Philippines Needle-Free Drug Delivery Systems Sales Growth Rate (2015-2020) (K Units)
Figure 83. Philippines Needle-Free Drug Delivery Systems Revenue Growth Rate (2015-2020) (US$ Million)
Figure 84. Vietnam Needle-Free Drug Delivery Systems Sales Growth Rate (2015-2020) (K Units)
Figure 85. Vietnam Needle-Free Drug Delivery Systems Revenue Growth Rate (2015-2020) (US$ Million)
Figure 86. Latin America Needle-Free Drug Delivery Systems Sales Growth Rate 2015-2020 (K Units)
Figure 87. Latin America Needle-Free Drug Delivery Systems Revenue Growth Rate 2015-2020 (US$ Million)
Figure 88. Latin America Needle-Free Drug Delivery Systems Sales Market Share by Co
  • Global Nuclear Medicine Cyclotron Systems Market Report, History and Forecast 2018-2029
    Published: 11-Jan-2024        Price: US 3350 Onwards        Pages: 118
    The global Nuclear Medicine Cyclotron Systems market was valued at US$ 220.85 million in 2022 and will reach US$ 283.75 million by the end of 2029, growing at a CAGR of 4.38% during 2023-2029. Asia-Pacific market for Nuclear Medicine Cyclotron Systems was valued at $ 61.16 million in 2022 and will reach $ 104.22 million by 2029, at a CAGR of 5.84% during the forecast period of 2023 through 2029. Report Scope This report aims to provide a comprehensive presentation of the glo......
  • Global Non-imaging Diagnostic Catheter Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 95
    The global Non-imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
  • Global Imaging Diagnostic Catheter Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 90
    The global Imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated......
  • Global PCR Equipment Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 77
    The global PCR Equipment market was valued at US$ 806 million in 2023 and is anticipated to reach US$ 1230.7 million by 2030, witnessing a CAGR of 6.7% during The forecast period 2024-2030. PCR (Polymerase Chain Reaction) equipment is widely used in molecular biology and genetics research for amplifying DNA and RNA sequences. The market for PCR equipment is influenced by several key drivers. Here are some of The significant market drivers: Advancements in Research and Diagnost......
  • Global Disposable Sterile Syringes and Needles Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 109
    The global Disposable Sterile Syringes and Needles market was valued at US$ 404.4 million in 2023 and is anticipated to reach US$ 539.1 million by 2030, witnessing a CAGR of 2.1% during The forecast period 2024-2030. North American market for Disposable Sterile Syringes and Needles is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Disposable Sterile Syringes and N......
  • Global Orthopaedic Power Tools Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106
    The global Orthopaedic Power Tools market was valued at US$ 463.3 million in 2023 and is anticipated to reach US$ 746.5 million by 2030, witnessing a CAGR of 7.3% during The forecast period 2024-2030. North American market for Orthopaedic Power Tools is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Orthopaedic Power Tools is estimated to increase from $ million i......
  • Global Cerebrospinal Fluid Management Devices Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Cerebrospinal Fluid Management Devices market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Cerebrospinal Fluid Management Devices is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Cerebrospinal Fluid Management Devices is estimate......
  • Global CAD & CAM Milling Burs Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 79
    The global CAD & CAM Milling Burs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ ......
  • Global Artificial Teeth Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 98
    The global Artificial Teeth market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, a......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs